Concepedia

Isabella Syring

IS

Statistics

Publications

18

Citations

851

H-Index

15

Active since

2009

Affiliations

University Hospital Bonn(Current)

Prostate Cancer Research

Klinik und Poliklinik für Urologie

University of Regensburg

University of Bonn

Isabella Syring is an author at University Hospital Bonn specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2009–2021

18

Publications

18

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer

Isabella Syring, Joanna Bartels, Stefan Holdenrieder et al. · The Journal of Urology · 2014 · 197 citations

, , +17

Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer

Johannes Brägelmann, Niklas Klümper, Anne Offermann et al. · Clinical Cancer Research · 2016 · 113 citations

, , +17

Identification of novel long non-coding RNAs in clear cell renal cell carcinoma

Jasmine JC Blondeau, Mario C. Deng, Isabella Syring et al. · Clinical Epigenetics · 2015 · 88 citations · Full text

, , +17

Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma

Sarah Schrödter, Martin Braun, Isabella Syring et al. · Molecular Cancer · 2016 · 71 citations · Full text

, , +17

The long non-coding RNA lnc-ZNF180-2 is a prognostic biomarker in patients with clear cell renal cell carcinoma.

Jörg Ellinger, Jahedul Alam, Jannik Rothenburg et al. · PubMed · 2015 · 64 citations

, , +17

1–5 of 18